Deutsche Bank’s Anixa Biosciences ANIX Stock Holding History

Deutsche Bank’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-7,711	Closed	-$27K	–	4858
2019 Q2	$27K	Buy	+7,711	New	+$32.6K	﹤0.01%	4724
2018 Q2	–	Sell	-1,102	Closed	-$4K	–	5394
2018 Q1	$4K	Buy	1,102 +100	+10%	+$385	﹤0.01%	5250
2017 Q4	$2K	Buy	+1,002	New	+$2.6K	﹤0.01%	4908
2017 Q1	–	Sell	-135	Closed	–	–	4886
2016 Q4	$0	Buy	+135	New	+$750	﹤0.01%	4893
2015 Q4	–	Sell	-2,930	Closed	-$13K	–	5254
2015 Q3	$13K	Buy	+2,930	New	+$13.6K	﹤0.01%	4884

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Deutsche Bank's ANIX Position: Q3 2019 in Review

Deutsche Bank sold out of Anixa Biosciences (ANIX) in Q3 2019, closing a stake of 7,711 shares — an estimated $27K sold.

Deutsche Bank first reported a position in ANIX in Q3 2015 and held it in 5 quarters. The position peaked at $27K in Q2 2019. 17 funds tracked by Wall St. Rank hold ANIX as of Q3 2019.

Deutsche Bank reported no remaining Anixa Biosciences position as of Q3 2019 after selling out during the quarter.
Deutsche Bank sold 7,711 Anixa Biosciences shares in Q3 2019, an estimated $27K.
Deutsche Bank first reported a position in Anixa Biosciences in Q3 2015 and held it in 5 quarters.
Deutsche Bank's Anixa Biosciences position peaked at $27K in Q2 2019.
17 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2019.

Based on Deutsche Bank's 13F filing for Q3 2019, filed 14 Nov 2019.